JACOB LEONARD S 4
4 · ANTARES PHARMA, INC. · Filed Dec 11, 2019
Insider Transaction Report
Form 4
JACOB LEONARD S
Director
Transactions
- Exercise/Conversion
Common Stock
2019-12-09$1.60/sh+80,000$128,000→ 377,563 total - Sale
Common Stock
2019-12-09$4.63/sh−80,000$370,536→ 297,563 total - Sale
Common Stock
2019-12-09$4.63/sh−84,814$392,833→ 212,749 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-09−80,000→ 0 totalExercise: $1.60From: 2011-05-27Exp: 2020-05-26→ Common Stock (80,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-12-09−80,000→ 0 totalExercise: $1.66From: 2012-05-17Exp: 2021-05-16→ Common Stock (80,000 underlying) - Exercise/Conversion
Common Stock
2019-12-09$1.66/sh+80,000$132,800→ 377,563 total - Sale
Common Stock
2019-12-09$4.62/sh−80,000$369,776→ 297,563 total